Crosol Crop Care Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 13-12-2024
- Paid Up Capital ₹ 3.00 Cr
as on 13-12-2024
- Company Age 10 Year, 7 Months
- Last Filing with ROC 31 Mar 2016
- Open Charges ₹ 11.00 Cr
as on 13-12-2024
- Revenue 538.74%
(FY 2016)
- Profit 952.75%
(FY 2016)
- Ebitda 567.15%
(FY 2016)
- Net Worth 102.15%
(FY 2016)
- Total Assets 145.11%
(FY 2016)
About Crosol Crop Care
The Corporate was formerly known as Hemasree Biotech Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2016. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 3.00 Cr.
The company currently has active open charges totaling ₹11.00 Cr.
Belide Rani and Belide Naveen serve as directors at the Company.
- CIN/LLPIN
U24233TG2014PTC094577
- Company No.
094577
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Jun 2014
- Date of AGM
30 Sep 2016
- Date of Balance Sheet
31 Mar 2016
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Warangal, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Crosol Crop Care?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Belide Rani  | Director | 23-Jun-2014 | Current |
| Belide Naveen | Director | 23-Jun-2014 | Current |
Financial Performance of Crosol Crop Care.
Crosol Crop Care Private Limited, for the financial year ended 2016, experienced significant growth in revenue, with a 538.74% increase. The company also saw a substantial improvement in profitability, with a 952.75% increase in profit. The company's net worth Soared by an impressive increase of 102.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Crosol Crop Care?
In 2016, Crosol Crop Care had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shakthisri Bio Crop Sciences Private LimitedActive 11 years 2 monthsBelide Naveen is a mutual person
Charges (Loans)
₹11.00 Cr
₹0
Charges Breakdown by Lending Institutions
- Bank Of India : 11.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Jan 2015 | Bank Of India | ₹11.00 Cr | Open |
How Many Employees Work at Crosol Crop Care?
Crosol Crop Care has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Crosol Crop Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Crosol Crop Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
